Public-registry site landscape for NCT03684785, a Advanced or Metastatic Merkel Cell Carcinoma study sponsored by Exicure, Inc.. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT03684785 (registry record) |
| Sponsor | Exicure, Inc. |
| Condition(s) | Advanced or Metastatic Merkel Cell Carcinoma; Advanced or Metastatic Cutaneous Squamous Cell Carcinoma; Advanced or Metastatic Melanoma; Advanced or Metastatic Head and Neck Squamous Cell Carcinoma |
| Phase | PHASE1 / PHASE2 |
| Listed sites | 26 |
| Site countries | United States |
Eichor generates a preliminary site-risk snapshot for NCT03684785 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →